ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to loss of muscle control and eventual paralysis.
Hyperbaric oxygen therapy may potentially slow down the progression of Amyotrophic Lateral Sclerosis (ALS) by reducing inflammation and promoting neuronal survival through enhanced oxygen delivery to affected tissues.